Novo Nordisk to Acquire Obesity Drug Developer Inversago ...Middle East

Novo Nordisk has said it would acquire Canadian company Inversago Pharma in a $1.07 billion deal including the development of an appetite regulator. Reuters Health Information

Hence then, the article about novo nordisk to acquire obesity drug developer inversago was published today ( Friday 11/08/2023 - 04:40 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk to Acquire Obesity Drug Developer Inversago )

Also on site :

• The New Infrastructure of Social Growth: Why SaaS Startups Are Moving Beyond Emulators with GeeLark Cloud Phone
• Kremlin responds to ‘borderline crazy’ threat from NATO state
• This Landmark Was Just Ranked ‘Most Loved in the World’—and It's Not the Eiffel Tower